Zijp Anne, Versluis Anke, Joosse Laura, Kind Taco, Rouveroy van Nieuwaal Tess Mj, Wassink-Bergman Chantal, van Veen Ilonka Hpaa, Weersink Els Jm, Chavannes Niels H, Aardoom Jiska J
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
National eHealth Living Lab, Leiden, Netherlands.
Digit Health. 2024 Nov 5;10:20552076241292391. doi: 10.1177/20552076241292391. eCollection 2024 Jan-Dec.
Asthma control is often suboptimal, which is associated with incorrect medication use and poor asthma management by patients. Astmakompas, a digital self-management intervention, comprises a mobile app for patients, a web portal for healthcare professionals (HCP), and a wireless spirometer. Together, these components are intended to facilitate symptom monitoring, patient-HCP communication and assist in asthma-related self-management.
The pilot study primarily aims to assess the feasibility, acceptability, usability and safety of Astmakompas from patient and HCP perspectives, and secondarily to explore potential effects on asthma control, medication use, Quality of Life, self-efficacy and (in)direct costs.
A mixed-method, multi-center, pre-post study design was conducted in two Dutch hospitals, involving patients with uncontrolled asthma and four HCPs. Primary outcomes were assessed post-intervention using questionnaires and in-depth interviews. Secondary outcomes were assessed at baseline and post-intervention using questionnaires, and post-intervention using in-depth interviews.
In general, the data show that Astmakompas was considered feasible, acceptable, usable and safe by both patients (= 14) and HCPs (= 4). Furthermore, qualitative data of 11 patients and all HCPs showed the importance of guidance from HCPs and tailoring of Astmakompas to care needs. Astmakompas helped patients recognise symptoms and provided valuable insights into asthma control while being easy to use. Asthma control improved from baseline (= 2.1, = 1.3) to post-intervention (= 1.3, = 1.0, (13) = 2.61; = .02).
Astmakompas shows promise for further implementation and research. Future randomized studies with longer evaluation periods are crucial to assess the tool's impact on asthma outcomes and workload. It is important that HCPs guide and tailor interventions to meet the patient's individual needs and circumstances.
哮喘控制通常未达到最佳状态,这与患者用药不当和哮喘管理不善有关。Astmakompas是一种数字自我管理干预措施,包括一款面向患者的移动应用程序、一个面向医疗保健专业人员(HCP)的门户网站以及一台无线肺活量计。这些组件共同旨在促进症状监测、患者与HCP之间的沟通,并协助进行与哮喘相关的自我管理。
该试点研究主要旨在从患者和HCP的角度评估Astmakompas的可行性、可接受性、可用性和安全性,其次是探索其对哮喘控制、药物使用、生活质量、自我效能和(直接/间接)成本的潜在影响。
在荷兰的两家医院进行了一项混合方法、多中心、干预前后研究设计,纳入哮喘控制不佳的患者和四名HCP。干预后使用问卷和深入访谈评估主要结局。使用问卷在基线和干预后评估次要结局,并在干预后使用深入访谈评估。
总体而言,数据表明患者(n = 14)和HCP(n = 4)都认为Astmakompas是可行的、可接受的、可用的和安全的。此外,11名患者和所有HCP的定性数据表明了HCP指导以及使Astmakompas适应护理需求的重要性。Astmakompas帮助患者识别症状,并在易于使用的同时提供了有关哮喘控制的宝贵见解。哮喘控制从基线(M = 2.1,SD = 1.3)改善到干预后(M = 1.3,SD = 1.0,t(13) = 2.61;p = .02)。
Astmakompas显示出进一步实施和研究的前景。未来进行更长评估期的随机研究对于评估该工具对哮喘结局和工作量的影响至关重要。HCP指导并调整干预措施以满足患者的个体需求和情况非常重要。